Breast Cancer News and reporting on breast cancer. Lynparza Benefit in Early BRCA-Mutated Breast Cancer Reignites Universal Genetic Testing Discussion Premium The OlympiA trial showed a disease-free survival benefit with adjuvant PARP inhibitor therapy for early-stage, BRCA1/2-mutated, HER2-negative breast cancer patients. Myriad Genetics Recalibrates Breast Cancer PRS for All Ancestries in Anticipation of Broader Launch Premium At ASCO, the company detailed its efforts to make the 93-SNP riskScore, which it plans to offer as a standalone DTC test next year, relevant for women of all ancestries. Breast Cancer Genomics Study Reveals Recurrent Contributors to Treatment Resistance in Early Disease Researchers saw convergent subclones crop up in early-stage, estrogen receptor-positive breast cancers that dodged endocrine- and CDK4/6 inhibitor-based therapies. Postponed CMS Proposal Would Remove Unspecified Cancer Dx Codes, Impacting Test Access Premium The proposed change would delete payable cancer codes if they contain the word "unspecified" even if the word is included in a code that doesn't impact coverage. AACR Presentations Highlight Power of Large Tumor Atlases in Studies of Cancer Progression Premium The talks focused on studies stemming from the Cancer Moonshot initiative's Human Tumor Atlas Network project, which is readying its first data release. May 12, 2021 Heligenics, Jackson Lab Partner to Study Breast Cancer Gene Variants May 7, 2021 Breast Cancer Immunotherapy Response Markers Emerge From Single-Cell Sequencing Study Apr 22, 2021 Todos Medical Acquires Provista Diagnostics for $7.5M Apr 15, 2021 Wellcome Leap Launches $55M Program to Develop Disease-Specific Tissue Profiling Platforms Apr 15, 2021 At ACMG, Mechanism for Common Breast Cancer Locus Proposed From Functional Analysis Apr 14, 2021 Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries Mar 25, 2021 Startup Tethis Targets Early-Stage Breast Cancer Detection With CTC Sample Prep Platform Premium Mar 18, 2021 Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests Premium Mar 11, 2021 Broad Team to Improve Minimal Residual Disease Detection With Mutation Enrichment Sequencing Method Premium Mar 10, 2021 Datar Cancer Genetics Obtains CE Mark for Liquid Biopsy Cancer Test Mar 2, 2021 Molecular Health Inks Agreement for Precision Medicine Tools With Falco Biosystems Mar 2, 2021 PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment Premium Feb 24, 2021 Syapse Plans Deeper Dive Into Large Health Systems for Data-Driven Cancer Insights Premium Feb 23, 2021 PreludeDx, GenesisCare Partner to Increase Access to Breast Cancer Testing Feb 22, 2021 Theralink Partners With George Mason, Rutgers Cancer Institute on Breast Cancer Test Feb 19, 2021 BRCA2 Variants of Unknown Significance Reclassified Through Functional Data Additions Feb 17, 2021 Exact Sciences Sketches Out Strategy for End-to-End Cancer Testing With Ashion Acquisition Premium Feb 17, 2021 NCI Grants $1.9M to Roswell Park to Study Molecular Race-Based Breast Cancer Disparities Jan 21, 2021 Breast Cancer Risk Gene Associations Refined in Large-Scale Studies Jan 21, 2021 OncoLab Diagnostics Targets Cancer Recurrence Monitoring with CTC-Derived Biomarker Assay Premium Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.